Privacy    
 
  Citi Research Disclosures


ABCDEFGHIJKLMNOPQRSTUVWXYZ#




Disclosures Home
Conflicts Management Policy
SEBI Investor Charter & Complaint Information
Staff Conflicts
Terms of Use

 
Valuation & Risks ( ADM ) Disclosure / Price Chart(s) / Valuation & Risk
Fundamental Equity Research
We use a sum-of-the-parts method to value ADM shares, which applies EV/EBITDA to each of the company’s estimated segment earnings for CY26E. We use a 7.5x multiple for Ag Services and Oilseeds, 6.0x for Carbohydrate Solutions, 9.0x for Nutrition, and 6.0x for Other. This works out to a weighted average EV/EBITDA multiple of 7.3x and a target price of $51 per share.

ADM’s upside risks to our target price include: 1) Crush margins could be stronger than the futures curve suggests; and 2) The Nutrition business could rebound faster than expected. The accounting issues and restatements might not result in significant earnings revisions overall.
 
ADM’s downside risks to our target price include: 1) Crush margins could erode further; and 2) Ag Services margins could be worse than expected. 3) The ongoing accounting review and subsquent restatements could result in significant revisions – and take a long time to complete.

 

 

citiPrivacy
www.citigroup.com Terms, conditions, caveats, and small print
Copyright © 2025 Citi